Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.

Liu, Yu-Qing; Wu, Fan; Li, Jing-Jun; Li, Yang-Fang; Liu, Xing; Wang, Zheng; Chai, Rui-Chao

Liu, Yu-Qing; Wu, Fan; Li, Jing-Jun; Li, Yang-Fang; Liu, Xing; Wang, Zheng; Chai, Rui-Chao.

Afiliação

Liu YQ; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Beijing, China.
Wu F; Chinese Glioma Genome Atlas Network, Beijing, China.
Li JJ; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Beijing, China.
Li YF; Chinese Glioma Genome Atlas Network, Beijing, China.
Liu X; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Beijing, China.
Wang Z; Chinese Glioma Genome Atlas Network, Beijing, China.
Chai RC; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Beijing, China.

Front Oncol ; 9: 1433, 2019.

Article em En | MEDLINE | ID: mdl-31921684

Palavras-chave

GBM; IDH wildtype; biomarker; glioma; prognosis; risk signature

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google